Total Funding
5
1
Total FundingVenture - Series Unknown raised
Growth Score
-10 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
621758
AngioScore develops scoring balloon catheters to treat cardiovascular and peripheral artery diseases.
Acquired by 
Spectranetics
James Andrews: SVP & CFOPast Role: Orquest, Variety of positions
Thomas R. Trotter: President, CEOPast Role: Mallinckrodt, President, Critical Care Division
About the Company
AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets.
Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.
